Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Non-small cell lung cancer active compounds discovery holding on protein expression using machine learning models

IAES International Journal of Artificial Intelligence · Vol. 14 No. 4 (2025) · hlm. 2815–2825

DOI
10.11591/ijai.v14.i4.pp2815-2825
ISSN
2252-8938, 2089-4872
Terbit
2025-08-01
Penerbit
Institute of Advanced Engineering and Science
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Computational methods have transformed the field of drug discovery, which significantly helped in the development of new treatments. Nowadays, researchers are exploring a wide ranger of opportunities to identify new compounds using machine learning. We conducted a comparative study between multiple models capable of predicting compounds to target non-small cell lung cancer, we focused on integrating protein expressions to identify potential compounds that exhibit a high efficacy in targeting lung cancer cells. A dataset was constructed based on the trials available in the ChEMBL database. Then, molecular descriptors were calculated to extract structure-activity relationships from the selected compounds and feed into several machine learning models to learn from. We compared the performance of various algorithms. The multilayer perceptron model exhibited the highest F1 score, achieving an outstanding value of 0,861. Moreover, we present a list of 10 drugs predicted as active in lung cancer, all of which are supported by relevant scientific evidence in the medical literature. Our study showcases the potential of combining protein expression analysis and machine learning techniques to identify novel drugs. Our analytical approach contributes to the drug discovery pipeline, and opens new opportunities to explore and identify new targeted therapies.

Kata kunci

Jaringan kolaborasi para penulis

6 penulis · 7 tautan kepenulisan bersama · 1 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Abdelmalek Essaâdi University
  • Sidi Mohamed Ben Abdellah University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohamed Taj BennaniSidi Mohamed Ben Abdellah University1
Sara AhsainAbdelmalek Essaâdi University1
Yasyn ElyusufiAbdelmalek Essaâdi University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://ijai.iaescore.com/index.php/IJAI/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Non-small cell lung cancer active compounds discovery holding on protein expression using machine learning models</dc:title>
	<dc:creator>Hanafi, Hamza</dc:creator>
	<dc:creator>Aït Kbir, M’hamed</dc:creator>
	<dc:creator>Rossi Hassani, Badr Dine</dc:creator>
	<dc:subject xml:lang="en-US">Artificial intelligence; bioinformatics</dc:subject>
	<dc:subject xml:lang="en-US">Drug discovery; Lung cancer; Machine learning models; Precision medicine; Protein expressions</dc:subject>
	<dc:description xml:lang="en-US">Computational methods have transformed the field of drug discovery, which significantly helped in the development of new treatments. Nowadays, researchers are exploring a wide ranger of opportunities to identify new compounds using machine learning. We conducted a comparative study between multiple models capable of predicting compounds to target non-small cell lung cancer, we focused on integrating protein expressions to identify potential compounds that exhibit a high efficacy in targeting lung cancer cells. A dataset was constructed based on the trials available in the ChEMBL database. Then, molecular descriptors were calculated to extract structure-activity relationships from the selected compounds and feed into several machine learning models to learn from. We compared the performance of various algorithms. The multilayer perceptron model exhibited the highest F1 score, achieving an outstanding value of 0,861. Moreover, we present a list of 10 drugs predicted as active in lung cancer, all of which are supported by relevant scientific evidence in the medical literature. Our study showcases the potential of combining protein expression analysis and machine learning techniques to identify novel drugs. Our analytical approach contributes to the drug discovery pipeline, and opens new opportunities to explore and identify new targeted therapies.</dc:description>
	<dc:publisher xml:lang="en-US">Institute of Advanced Engineering and Science</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2025-08-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijai.iaescore.com/index.php/IJAI/article/view/26113</dc:identifier>
	<dc:identifier>10.11591/ijai.v14.i4.pp2815-2825</dc:identifier>
	<dc:source xml:lang="en-US">IAES International Journal of Artificial Intelligence (IJ-AI); Vol 14, No 4: August 2025; 2815-2825</dc:source>
	<dc:source>2252-8938</dc:source>
	<dc:source>2089-4872</dc:source>
	<dc:source>10.11591/ijai.v14.i4</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijai.iaescore.com/index.php/IJAI/article/view/26113/14639</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Institute of Advanced Engineering and Science</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>